The largest database of trusted experimental protocols

4 protocols using garcinol

1

Intrathecal BDNF Antagonist and Autonomic Modulators in TNBS-Induced Chronic Pain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty-two gauge catheters were inserted through the atlanto-occipital membrane and extended to LS spinal cord segment. The location of each catheter was confirmed following euthanasia. Rats received either BDNF antagonist trkB-Fc (R&D Systems, Minneapolis, MN), 5 μg in 10 μl sterile saline or saline twice/day for seven days following adult TNBS application. Propranolol+phentolamine (50 μg each in 10 μl sterile saline) were administered in each rat daily for seven days following adult TNBS application. In separate groups of adult rats, peripheral propranolol+phentolamine cocktail was administered i.p. at 2 mg/kg each in saline once daily for seven days starting with the day of TNBS administration. Garcinol (Tocris Minneapolis, MN) was dissolved in DMSO and diluted to 4 nmol per μl in 50% DMSO/water. Garcinol was administered intrathecally via an osmotic pump (model 2001, Durect Corporation, Cupertino, CA) at a flow rate of 4 nmol per hour over a period of 7 days.
+ Open protocol
+ Expand
2

Excitotoxicity and AMPAR Stimulation in OPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solutions of L‐glutamate (100 mM, Sigma‐Aldrich Company Ltd, Dorset, UK) and AMPA (100 mM, Abcam, Cambridge, UK) were prepared in distilled water, while cyclothiazide (CTZ, 100 mM, Bio‐Techne Ltd/R&D Systems, Abingdon, UK) and Garcinol (10 mM, Tocris Bioscience, Abingdon, UK) were prepared in DMSO. Drugs were diluted in Sato medium for application to Oli‐neu cells or OPC medium for experiments using pOPC. AMPA was applied with CTZ (AMPA/CTZ; both at 100 µM) for 5 hr to induce excitotoxicity (Alberdi et al., 2002), or at 200 µM (without CTZ) for 24 hr for non‐pathological AMPAR stimulation (AMPA24h; Yuan et al., 1998). In experiments using pOPC CTZ was applied at 50 µM. Garcinol was used at 10 µM for gene expression, Western blot, and ChIP experiments. This concentration was selected based on pilot studies examining treatment with log concentrations of Garcinol (1–1,000 µM), in which concentrations >10 µM caused catastrophic cell detachment and death (data not shown). BrdU (Sigma‐Aldrich Company Ltd) stocks were prepared as described by Fannon et al. (2015).
+ Open protocol
+ Expand
3

Metabolic Modulation in Jurkat T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Jurkat T cells were cultured in R10FBS supplemented with 2 mM glutamine. Chemicals and inhibitors used in this study were as follows: 2-DG (10 mM), Akti1/2 (10 μM), Osi-027 (10 μM), KU-0063794 (10 μM), Rotenone (1 μM), TTFA (200 μM), Antimycin A (2 μM), Oligomycin (0.1 or 1 μM) or 4-(trifluoromethoxy) phenylhydrazone (FCCP, 2 μM), Clotrimazol (25 μM), nocodazole (10 μM), oxamate (5 mM), methyl pyruvate (1 or 10 mM), bifonazole (25 µM), MB-3 (1, 10 µM), 2-NBDG (0.5 mM) and mitotempo (20 μM) (all from Sigma-Aldrich). TCS-2002 (10 µM), SB 204990 (3 µM) and garcinol (1, 10 µM) (Tocris) was used at 10 μM. VDAC peptides corresponding to loop 4 (LP4 - KKLETAVNLAWTAGNSN) flanked N-, and C-terminally by the tryptophan zipper motif for increased stability (SWTWE and KWTWK, respectively) were linked to tandem repeats of the DNP2 fusion peptide (KIKKVKKKGRKKIKKVKKKGRK). The complete sequence for the peptides used are: dNP2 (KIKKVKKKGRKKIKKVKKKGRKSWTWEKWTWK) and dNP2-VDAC (KIKKVKKKGRKKIKKVKKKGRKSWTWEKKLETAVNLAWTAGNSNKWTWK). Both peptides were synthesized by Biomatik.
+ Open protocol
+ Expand
4

Erythrocyte Preservation and Garcinol Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 21°C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl 2 at 37°C for 24 h. Where indicated, erythrocytes were exposed to garcinol (Tocris bioscience, Bristol, UK) at the indicated concentrations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!